Statistical methods in oncology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Hazard ratio
Log-rank test
Cochran-Mantel-Haenszel test
Odds ratio
Cox proportional-hazards model
Fisher exact test
Risk difference
Stratified log-rank test
All oncology trials
2,067 results
- PREPAREIndependent statistical analysis of PRevention Using EPA Against coloREctal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04216251).
- PRESERVEIndependent statistical analysis of Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRESIDEIndependent statistical analysis of A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking…
- Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010021).
- Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration: Complete Statistical AnalysisIndependent statistical analysis of Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00203502).
- PRIMCABIndependent statistical analysis of Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide: primary endpoint results,…
- PRIMEIndependent statistical analysis of the PRIME phase 3 trial of panitumumab plus FOLFOX versus FOLFOX alone in metastatic colorectal cancer, including progression-free survival, overall survival, objective response, and statistical methodology.
- PRIORITIIndependent statistical analysis of A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.: primary endpoint results,…
- Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.: Complete Statistical AnalysisIndependent statistical analysis of Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: primary endpoint results, effect estimate with confidence…
- PROCLAIMIndependent statistical analysis of the PROCLAIM phase 3 trial, including its randomized design, overall survival analysis, progression-free survival, response, relapse patterns, swallowing outcomes, safety, statistical methods, and interpretation.
- PRODIGE 18Independent statistical analysis of PRODIGE 18, a randomized phase 2 trial evaluating chemotherapy associated with either cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer after progression following first-line bevacizumab.
- PRODIGE 22-ECKINOXEAn independent statistical analysis of PRODIGE 22-ECKINOXE, a randomized phase 2 trial of perioperative chemotherapy strategies in locally advanced colon cancer, focusing on histological tumor response and the statistical methods appropriate for…
- PRODIGE 23Independent statistical analysis of PRODIGE 23, a phase 3 randomized trial evaluating neoadjuvant mFolfirinox in patients with resectable locally advanced rectal cancer.
- PRODIGE 24Independent statistical analysis of PRODIGE 24, a phase 3 randomized trial comparing adjuvant mFOLFIRINOX with gemcitabine in resected pancreatic adenocarcinoma.
- PRODIGE 44Independent statistical analysis of PRODIGE 44, a randomized phase 2 trial evaluating neoadjuvant mFolfirinox with or without preoperative concomitant chemoradiotherapy in borderline resectable pancreatic carcinoma, with emphasis on the R0 resection margin…
- PROFILE 1014Independent statistical analysis of PROFILE 1014, evaluating crizotinib versus pemetrexed plus cisplatin or carboplatin in ALK-positive non-squamous lung cancer, with detailed interpretation of progression-free survival, overall survival, response, patient-reported outcomes, and statistical…
- Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers: Complete Statistical AnalysisIndependent statistical analysis of Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276885).
- Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: Complete Statistical AnalysisIndependent statistical analysis of Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PROSELICAA detailed statistical analysis of the phase 3 PROSELICA trial comparing cabazitaxel 20 mg/m² with 25 mg/m² plus prednisone in metastatic castration resistant prostate cancer, including non-inferiority methodology, overall survival, progression endpoints,…
- ProspectIndependent statistical analysis of A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer: primary endpoint results, effect estimate with…
- Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett’s Esophagus Compared With Standard Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PROTECTIndependent statistical analysis of the randomized phase 3 PROTECT trial of sipuleucel-T in prostate cancer, including its time-to-biochemical-failure endpoints, stratified log-rank analysis, hazard ratio, confidence interval, and statistical interpretation.
- PROTECTIndependent statistical analysis of Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Protocol for Women at Increased Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Protocol for Women at Increased Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00291135).
- Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00592592).
- Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340495).
- Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01288235).
- PRP vs Corticosteroid in Baker’s Cyst: Complete Statistical AnalysisIndependent statistical analysis of PRP vs Corticosteroid in Baker's Cyst: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02249377).
- PSMA PreRPIndependent statistical analysis of Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919111).
- PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176497).
- PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02383498).
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- R-CHOPIndependent statistical analysis of Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- R21 India Pal-Care Evaluation: Complete Statistical AnalysisIndependent statistical analysis of R21 India Pal-Care Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04972630).
- RAD 2003Independent statistical analysis of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04743934).